Event

FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law

May 7, 2020

Where:
Ronald Reagan Building and International Trade Center
1300 Pennsylvania Avenue NW
Washington, DC 20004

Sheppard Mullin Participants:
Allison Fulton - "Innovative and Breakthrough Devices and Evolving Regulatory Pathways," May 7, 2:40–3:40 p.m
Christopher Van Gundy - "Food for Thought: Personalized Nutrition, 'Functional Foods', and FDA Regulation" May 7, 2:40–3:40 p.m

About:
The premier conference for the food and drug law community, the FDLI Annual Conference addresses complex legal, regulatory, compliance, and policy issues across all facets of FDA-regulated industry. The two-day event provides in-depth discussions and analyses on a wide variety of timely topics by bringing together experts from the federal government, industry, the private bar, non-profits, patient and consumer advocates, consulting organizations, and academia.

Conference Highlights: 

  • Hear FDA’s 2020 strategic priorities directly from the FDA Commissioner, Chief Counsel, Center Directors, and other key leaders within the Agency
  • Join 900 high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding
  • Select from over 35 breakout sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues
  • Learn from more than 100 well-known officials and experts
  • Hear about the Top Cases in Food and Drug Law
  • Network and build relationships with seasoned law, regulatory, compliance, marketing/advertising, and management professionals

Key FDA Speakers:

  • Stacy Cline Amin, Chief Counsel, FDA
  • Peter W. Marks, Director, Center for Biologics Evaluation and Research, FDA  
  • Susan T. Mayne, Director, Center for Food Safety and Applied Nutrition, FDA
  • Jeffrey E. Shuren, Director, Center for Devices and Radiological Health, FDA
  • Steven M. Solomon, Director, Center for Veterinary Medicine, FDA
  • Janet Woodcock, Director, Center for Drug Evaluation and Research, FDA
  • Mitchell R. Zeller, Director, Center for Tobacco Products, FDA

Click here for more information and registration.

Share Via: